The Clinical Efficacy of DFPP in Patients With AAGN
NCT02294344
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
14
Enrollment
OTHER
Sponsor class
Stopped
The recruitment of subject is very difficult.
Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Interventions
OTHER:
DFPP&CTX
DRUG:
CTX
Sponsor
Zhi-Hong Liu, M.D.